Government Healthcare Policy, Business and Technology

Key Senate, House lawmakers tell HRSA to do its work on 340B

Modern Healthcare: After months of oversight and legislative hearings, key House and Senate lawmakers say the Health Resources and Services Administration needs to work with its current resources before Congress grants the agency more authority over the 340B drug discount program—from fining drugmakers who knowingly overcharge 340B hospitals to determining how to set ceiling prices for drugs.

Capt. Krista Pedley, who oversees 340B as director of HRSA's Office of Pharmacy Affairs, has told the Senate health committee that the agency can't oversee and manage 340B effectively unless it has rulemaking authority over all aspects of the program. But the top Republicans and Democrats of the Senate health committee and House Energy and Commerce Committee in a letter on Monday said they are worried the agency isn't doing enough with the authority it already has.

Read article